Figure (Nar03 0002 01)
Chemical structure of the active ingredient in NAROPIN, represented with associated hydrochloride (HCl) and water (H2O) molecules.*
Naropin Injection, Solution
Product Images NDC 63323-286
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Naropin (NDC 63323-286). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Premierprorx Logo (Nar03 0002 02)
Vial (Nar03 0002 03)
NAROPIN 0.2% (ropivacaine hydrochloride) injection label showing 200 mg per 100 mL (2 mg/mL) strength. The label includes usage restrictions for infiltration, nerve block, and epidural administration only, with a 100 mL volume indicated. Labeler is Fresenius Kabi USA, LLC, and it notes no preservatives, specific storage conditions, and that the container closure is latex-free.*
Bottle (Nar03 0002 04)
Label for Naropin (ropivacaine hydrochloride) Injection, USP 0.2% strength, providing 400 mg per 200 mL (2 mg per mL). The label specifies the product is for infiltration, nerve block, and epidural administration only, not for intravenous use. It indicates a single-dose 200 mL vial by Fresenius Kabi USA, LLC and includes storage instructions and formulation details.*
Vial (Nar03 0002 05)
Label for Naropin Injection, USP 0.5% (5 mg/mL) ropivacaine hydrochloride solution in a 30 mL single-dose vial. The label includes storage instructions, active ingredient amounts, manufacturer Fresenius Kabi USA, and usage indications limited to infiltration, nerve block, and epidural administration only.*
Carton (Nar03 0002 06)
Label for Naropin 0.5% (ropivacaine hydrochloride) Injection, USP, 5 mg/mL in a 30 mL single-dose vial. The label specifies the total amount as 150 mg per 30 mL and states it is for infiltration, nerve block, and epidural administration only, not for intravenous use. Manufactured by Fresenius Kabi USA, LLC.*
Vial (Nar03 0002 07)
Label for Naropin (ropivacaine hydrochloride) Injection USP, 0.2% strength (2 mg per mL) in a 20 mL single-dose vial. The label states the product contains 40 mg per 20 mL and is for infiltration, nerve block, and epidural administration only, not for intravenous use. Manufactured by Fresenius Kabi USA, LLC.*
Vial (Nar03 0002 08)
Label for Naropin 0.2% (ropivacaine hydrochloride) Injection, USP with a strength of 2 mg/mL, totaling 40 mg per 20 mL vial. The label specifies use for infiltration, nerve block, and epidural administration only, not for intravenous use. It includes manufacturer information for Fresenius Kabi USA, LLC and storage instructions.*
Vial (Nar03 0002 09)
NAROPIN 0.5% (Ropivacaine Hydrochloride) Injection, USP 100 mg per 20 mL (5 mg per mL) single-dose vial. The label states it is for infiltration, nerve block, and epidural administration only, not for intravenous use. Manufactured by Fresenius Kabi USA, LLC, with storage instructions and ingredient details including ropivacaine HCl, sodium chloride, and sodium hydroxide or hydrochloric acid to adjust pH.*
Vial (Nar03 0002 10)
NAROPIN 0.5% (ropivacaine hydrochloride) injection label showing 5 mg/mL concentration in a 20 mL single-dose vial. The label includes usage instructions indicating it is for infiltration, nerve block, and epidural administration only, not for intravenous use. Labeler is Fresenius Kabi USA, LLC, with storage and solution handling details provided.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
